PharmaCielo Ltd.
PCLOF
Rank in Stocks
#29461
PharmaCielo Ltd., operating in conjunction with its subsidiary, is primarily... PharmaCielo Ltd., operating in conjunction with its subsidiary, is primarily engaged in the comprehensive cultivation, processing, and distribution of pharmaceutical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated medicinal products. Additionally, the company diversifies its offerings by providing telemedicine software. Its clientele spans a range of entities, such as health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies, across both Canada and Colombia. PharmaCielo also holds a strategic partnership with AssuredTrans Inc., and its corporate headquarters are situated in Toronto, Canada.
Share Price
$0.0382
Last synced: 2026-11-09
Market Cap
$7.79M
Change (1 day)
-2.05%
Change (1 year)
63.25%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PharmaCielo Ltd. (PCLOF)
Category
Healthcare
EPS for PharmaCielo Ltd. (PCLOF)
EPS as of June 2026 TTM: $-0.01
According to PharmaCielo Ltd.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of 0.00, an increase over its 2024 EPS of $-0.04.
EPS history for PharmaCielo Ltd. from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -89.56% |
| 2025 | 0.00 | -89.56% |
| 2024 | $-0.04 | -51.79% |
| 2023 | $-0.08 | 6.64% |
| 2022 | $-0.07 | -50.28% |
| 2021 | $-0.14 | -53.52% |
| 2020 | $-0.31 | 10.69% |
| 2019 | $-0.28 | -69.39% |
| 2018 | $-0.90 | 2,648.94% |
| 2017 | $-0.03 | -80.47% |
| 2016 | $-0.17 | 22.37% |
| 2015 | $-0.14 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -48,617.91% |
DE
|
|
| $6.08 | -45,455.22% |
DE
|
|
| $1.55 | -11,671.64% |
JP
|
|
| $3.66 | -27,413.43% |
CH
|
|
| $0.45 | -3,458.21% |
IL
|
Questions about PharmaCielo Ltd.'s earnings per share (EPS)
What is PharmaCielo Ltd.'s earnings per share (EPS)?
PharmaCielo Ltd.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.
What was PharmaCielo Ltd.'s earnings per share (EPS) in 2025?
In 2025, PharmaCielo Ltd.'s earnings per share (EPS) was 0.00, compared with $-0.04 in 2024.
How has PharmaCielo Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, PharmaCielo Ltd.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2020 ($-0.31).
How does PharmaCielo Ltd.'s earnings per share (EPS) compare with similar companies?
PharmaCielo Ltd.'s earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.